Literature DB >> 25132740

Current management of hepatocellular carcinoma.

Parissa Tabrizian1, Sasan Roayaie1, Myron E Schwartz1.   

Abstract

Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and leading cause of death among patients with cirrhosis. Treatment guidelines are based according to the Barcelona Clinic Liver Cancer staging system. The choice among therapeutic options that include liver resection, liver transplantation, locoregional, and systemic treatments must be individualized for each patient. The aim of this paper is to review the outcomes that can be achieved in the treatment of HCC with the heterogeneous therapeutic options currently available in clinical practice.

Entities:  

Keywords:  Barcelona Clinic Liver Cancer guidelines; Hepatocellular carcinoma; Management; Outcome; Therapeutic options

Mesh：

Substances：

Year:  2014        PMID： 25132740      PMCID： PMC4130831          DOI： 10.3748/wjg.v20.i30.10223

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  163 in total

1.  Living donor liver transplantation for hepatocellular carcinoma exceeding conventional criteria: questions, answers and demands for a common language.

Authors:  Pietro Majno; Vincenzo Mazzaferro
Journal:  Liver Transpl       Date:  2006-06       Impact factor: 5.799

2.  A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.

Authors:  L Lladó; J Virgili; J Figueras; C Valls; J Dominguez; A Rafecas; J Torras; J Fabregat; J Guardiola; E Jaurrieta
Journal:  Cancer       Date:  2000-01-01       Impact factor: 6.860

3.  Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.

Authors:  Wen-Yen Huang; Yee-Min Jen; Meei-Shyuan Lee; Li-Ping Chang; Chang-Ming Chen; Kai-Hsiung Ko; Kuen-Tze Lin; Jang-Chun Lin; Hsing-Lung Chao; Chun-Shu Lin; Yu-Fu Su; Chao-Yueh Fan; Yao-Wen Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-17       Impact factor: 7.038

4.  Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma.

Authors:  J I Herrero; B Sangro; J Quiroga; F Pardo; M Herraiz; J A Cienfuegos; J Prieto
Journal:  Liver Transpl       Date:  2001-07       Impact factor: 5.799

Review 5.  Liver transplantation for hepatocellular carcinoma.

Authors:  A W Hemming; D R Nelson; A I Reed
Journal:  Minerva Chir       Date:  2002-10       Impact factor: 1.000

6.  Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.

Authors:  John P Duffy; Andrew Vardanian; Elizabeth Benjamin; Melissa Watson; Douglas G Farmer; Rafik M Ghobrial; Gerald Lipshutz; Hasan Yersiz; David S K Lu; Charles Lassman; Myron J Tong; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

7.  Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

Authors:  Shi-Ming Lin; Chun-Jung Lin; Chen-Chun Lin; Chao-Wei Hsu; Yi-Cheng Chen
Journal:  Gastroenterology       Date:  2004-12       Impact factor: 22.682

8.  Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.

Authors:  Laura M Kulik; Brian I Carr; Mary F Mulcahy; Robert J Lewandowski; Bassel Atassi; Robert K Ryu; Kent T Sato; Al Benson; Albert A Nemcek; Vanessa L Gates; Michael Abecassis; Reed A Omary; Riad Salem
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

9.  Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study.

Authors:  Sandrine Faivre; Eric Raymond; Eveline Boucher; Jean Douillard; Ho Y Lim; Jun S Kim; Magaly Zappa; Silvana Lanzalone; Xun Lin; Samuel Deprimo; Charles Harmon; Ana Ruiz-Garcia; Maria J Lechuga; Ann Lii Cheng
Journal:  Lancet Oncol       Date:  2009-07-06       Impact factor: 41.316

10.  Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma.

Authors:  Han Chong Toh; Pei-Jer Chen; Brian I Carr; Jennifer J Knox; Sharlene Gill; Peter Ansell; Evelyn M McKeegan; Barry Dowell; Michelle Pedersen; Qin Qin; Jiang Qian; Frank A Scappaticci; Justin L Ricker; Dawn M Carlson; Wei Peng Yong
Journal:  Cancer       Date:  2012-07-25       Impact factor: 6.860
View more
  34 in total

1.  MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.

Authors:  Xiao-Jun Feng; Qing Pan; Shou-Mei Wang; Yun-Cui Pan; Qian Wang; Huan-Huan Zhang; Ming-Hua Zhu; Shu-Hui Zhang
Journal:  Tumour Biol       Date:  2016-03-24

2.  Niclosamide suppresses migration of hepatocellular carcinoma cells and downregulates matrix metalloproteinase-9 expression.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Oncol Lett       Date:  2015-10-09       Impact factor: 2.967

3.  High-resolution intravascular MRI-guided perivascular ultrasound ablation.

Authors:  Xiaoyang Liu; Nicholas Ellens; Emery Williams; Everette C Burdette; Parag Karmarkar; Clifford R Weiss; Dara Kraitchman; Paul A Bottomley
Journal:  Magn Reson Med       Date:  2019-08-11       Impact factor: 4.668

4.  KRT6B, a key mediator of notch signaling in honokiol-induced human hepatoma cell apoptosis.

Authors:  Haoxuan Zhang; Mingsheng Huo; Yin Jia; Ao Xu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 5.  Prognostic and clinicopathological significance of MACC1 expression in hepatocellular carcinoma patients: a meta-analysis.

Authors:  Da-Wei Sun; Ying-Yi Zhang; Yue Qi; Gui-Qi Liu; Yu-Guo Chen; Jian Ma; Guo-Yue Lv
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 6.  P15 gene methylation in hepatocellular carcinomas: a systematic review and meta-analysis.

Authors:  Wei-Hua Ren; Ya-Wei Li; Rui Li; Hong-Bo Feng; Jun-Long Wu; Hui-Rui Wang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

7.  Hypervascular Lesion in a Cirrhotic Liver: A Case Report.

Authors:  Lucas Carvalho Santos; Juliana Bianchi; Suzzanna Ingryd Goncalves Souza; Luiz Arnaldo Szutan
Journal:  Gastroenterology Res       Date:  2014-12-27

Review 8.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

9.  miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.

Authors:  Lin Chen; Haitao Guan; Chunyan Gu; Yali Cao; Jianguo Shao; Feng Wang
Journal:  Tumour Biol       Date:  2015-09-18

Review 10.  A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine.

Authors:  C Rory Goodwin; Vijay Yanamadala; Alejandro Ruiz-Valls; Nancy Abu-Bonsrah; Ganesh Shankar; Eric W Sankey; Christine Boone; Michelle J Clarke; Mark Bilsky; Ilya Laufer; Charles Fisher; John H Shin; Daniel M Sciubba
Journal:  World Neurosurg       Date:  2016-05-13       Impact factor: 2.104
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.